A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers
Clinical trial NCT02920931 · COMPLETED
Trial details
- NCT number
- NCT02920931
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.